385 related articles for article (PubMed ID: 34331705)
1. Towards PET imaging of the dynamic phenotypes of microglia.
Beaino W; Janssen B; Vugts DJ; de Vries HE; Windhorst AD
Clin Exp Immunol; 2021 Dec; 206(3):282-300. PubMed ID: 34331705
[TBL] [Abstract][Full Text] [Related]
2. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.
Beaino W; Janssen B; Kooij G; van der Pol SMA; van Het Hof B; van Horssen J; Windhorst AD; de Vries HE
J Neuroinflammation; 2017 Dec; 14(1):259. PubMed ID: 29273052
[TBL] [Abstract][Full Text] [Related]
3. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO.
Narayanaswami V; Dahl K; Bernard-Gauthier V; Josephson L; Cumming P; Vasdev N
Mol Imaging; 2018; 17():1536012118792317. PubMed ID: 30203712
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Neuroinflammation in Alzheimer's Disease.
Zhou R; Ji B; Kong Y; Qin L; Ren W; Guan Y; Ni R
Front Immunol; 2021; 12():739130. PubMed ID: 34603323
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
Tronel C; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Dupont AC; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398245
[TBL] [Abstract][Full Text] [Related]
6. PET Imaging of Microglial Activation-Beyond Targeting TSPO.
Janssen B; Vugts DJ; Windhorst AD; Mach RH
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518005
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
8. Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state.
Villa A; Klein B; Janssen B; Pedragosa J; Pepe G; Zinnhardt B; Vugts DJ; Gelosa P; Sironi L; Beaino W; Damont A; Dollé F; Jego B; Winkeler A; Ory D; Solin O; Vercouillie J; Funke U; Laner-Plamberger S; Blomster LV; Christophersen P; Vegeto E; Aigner L; Jacobs A; Planas AM; Maggi A; Windhorst AD
Theranostics; 2018; 8(19):5400-5418. PubMed ID: 30555554
[TBL] [Abstract][Full Text] [Related]
9. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
10. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
Janssen B; Mach RH
Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
[TBL] [Abstract][Full Text] [Related]
12. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
[TBL] [Abstract][Full Text] [Related]
13. Imaging Neuroinflammation in Neurodegenerative Disorders.
Masdeu JC; Pascual B; Fujita M
J Nucl Med; 2022 Jun; 63(Suppl 1):45S-52S. PubMed ID: 35649654
[TBL] [Abstract][Full Text] [Related]
14. Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.
Adhikari A; Chauhan K; Adhikari M; Tiwari AK
Bioorg Med Chem; 2024 Feb; 100():117628. PubMed ID: 38330850
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
Cerami C; Iaccarino L; Perani D
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration.
Beckers L; Ory D; Geric I; Declercq L; Koole M; Kassiou M; Bormans G; Baes M
Mol Imaging Biol; 2018 Feb; 20(1):94-102. PubMed ID: 28695372
[TBL] [Abstract][Full Text] [Related]
17. The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.
Chen Z; Haider A; Chen J; Xiao Z; Gobbi L; Honer M; Grether U; Arnold SE; Josephson L; Liang SH
J Med Chem; 2021 Dec; 64(24):17656-17689. PubMed ID: 34905377
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
[TBL] [Abstract][Full Text] [Related]
19. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation in Neurodegenerative Disorders-a Review.
Schain M; Kreisl WC
Curr Neurol Neurosci Rep; 2017 Mar; 17(3):25. PubMed ID: 28283959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
